Patient Counseling for Finerenone

Main Article Content

Sanjay Kalra
Banshi Saboo
Beatrice Anne
Mathew John
Pradip Dalwadi
Shehla Shaikh


Finerenone is a nonsteroidal mineralocorticoid receptor antagonist, which is used to retard the progression of chronic kidney disease in persons with type 2 diabetes. This communication describes the various aspects of patient counseling needed to ensure safe and effective usage of the molecule. It utilizes the 5C checklist: Confirmation of clinical indication; Caveats and contraindications; Concerns and checkpoints; Caution and use with concomitant medication; and Constraints and cost, to create a simple, yet comprehensive tool for clinical use.

Article Details

How to Cite
Sanjay Kalra, Banshi Saboo, Beatrice Anne, Mathew John, Pradip Dalwadi, & Shehla Shaikh. (2023). Patient Counseling for Finerenone. Indian Journal Of Clinical Practice, 34(4), 28–30.
Brief Communication

Most read articles by the same author(s)

1 2 3 4 > >>